Modified Citrus Pectin Delays Progression of Prostate Cancer
Oral supplementation with modified citrus pectin (MCP)—an immunomodulatory compound derived from the peel and pulp of citrus fruits—can delay progression of biochemically relapsed prostate cancer (BRPC), according to a new study.